As a relevant footnote, SKTO company president Mayor seemed to be telegraphing a message by using the possessive adjective "our" four times in his quoted statement in the last press release(02/28/2014), three times in describing the Pharmajanes web platform and once describing Dharmanol.
02/28/2014 Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."
###
(Marketwired) - 02/28/14 - Medical Greens, a subsidiary of SK3 Group (OTC Pink: SKTO) is seeking qualified California medical marijuana patients to receive a free sample of its new, non-psychoactive medical cannabis product, Dharmanol Citrolene, developed by its Berkeley Bio-Organic Research Laboratory.
Dharmanol Citrolene contains CBD, a non-psychoactive "chemical cousin" to THC, the element in marijuana that makes people high or stoned. In addition, it contains phyto-cannabinoids in their non-psychoactive carboxylate form. It also contains d-limonene, a medicinal element found in cannabis, known as a terpene.
D-limonene has been shown to have a relaxing, anti-anxiety, anti-spasmodic effect. This is because it binds to the same receptors in the human body as do the pharmaceutical synthetics Valium and Xanax. Dharmanol Citrolene contains a healthy dose of organically-sourced d-limonene. Although the d-limonene used in Dharmanol Citrolene is chemically identical to that produced by the cannabis/hemp plant, it is actually sourced from the rind of citrus fruits.
Interestingly, research has shown d-limonene to have many properties that are similar to cannabis in their interaction with cancer. Sloan Kettering Cancer Center lists 19 very promising studies using this powerful natural medicine.
To participate in the Company's survey, an individual must be a medical cannabis patient with a valid physician recommendation and live in the State of California in one of the zip codes currently served by Pharmajanes.com. To see if you qualify, go to the website and check out the section labeled "Dharmanol Citrolene Promotion." Starting this upcoming Wednesday, March 5, 2014, individuals requesting the promotional product during the first 30 days, while supplies last, will receive a 2-pack of the product.
Dharmanol Citrolene will be available for sale soon after that through Pharmajanes and many dispensaries throughout California.
Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."
About AEGY
About SKTO
FDA Statement
Safe Harbor Statement